![Carlos de Sousa](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Carlos de Sousa
Chief Executive Officer at
Ultimovacs AB
Profile
Carlos de Sousa is currently the Chief Executive Officer at Ultimovacs AB and a Principal at the University of Lisbon.
Previously, he held positions such as President & Chief Executive Officer at Mendus AB from 2016 to 2019, Chief Executive Officer & Head-Investor Relations at Ultimovacs ASA, Senior Director at Pfizer Saudi Ltd., Independent Director at Ectin Research AB, Chief Business Officer at Newron Pharmaceuticals SpA, Chief Business Officer & Senior Vice President at Zealand Pharma A, Vice President & Head-Commercial Licensing at Takeda A, Senior Vice President at Schwartz Pharma AG, Chief Business Officer at to-BBB Holding BV, Chief Business Officer at to-BBB technologies BV, and Head-Negotiations at Novartis Pharma AG.
Dr. de Sousa holds a doctorate from the University of Lisbon and an MBA from The Leonard N Stern School of Business.
Carlos de Sousa active positions
| Companies | Position | Start |
|---|---|---|
University of Lisbon
 University of Lisbon Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Ultimovacs AB
 Ultimovacs AB Pharmaceuticals: MajorHealth Technology Engages in pharmaceutical development | Chief Executive Officer | - |
Former positions of Carlos de Sousa
| Companies | Position | End |
|---|---|---|
| MENDUS AB | Chief Executive Officer | 2019-12-12 |
| ECTIN RESEARCH AB | Director/Board Member | - |
Ultimovacs ASA
 Ultimovacs ASA Pharmaceuticals: MajorHealth Technology Develops novel peptide based therapeutic cancer vaccine | Chief Executive Officer | - |
Takeda A/S
 Takeda A/S Financial ConglomeratesFinance Engages in holding or owning securities of companies | Corporate Officer/Principal | - |
Novartis Pharma AG
 Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Corporate Officer/Principal | - |
Training of Carlos de Sousa
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
25
1st degree connections
14
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 14 |
|---|---|
Newron Pharmaceuticals SpA
 Newron Pharmaceuticals SpA Pharmaceuticals: MajorHealth Technology Develops and sells novel therapies central & peripheral nervous system | Health Technology |
Zealand Pharma A/S
 Zealand Pharma A/S BiotechnologyHealth Technology Operates as a biotechnology company that discovers and develops peptide based medicines | Health Technology |
Takeda A/S
Takeda A/S Financial ConglomeratesFinance Engages in holding or owning securities of companies | Finance |
Schwartz Pharma AG
 Schwartz Pharma AG Pharmaceuticals: MajorHealth Technology Schwartz Pharma AG is a German company. | Health Technology |
to-BBB Holding BV
 to-BBB Holding BV Pharmaceuticals: GenericHealth Technology Operates as a holding company with interests in providing central nervous system drug technology to the pharmaceutical and biotechnology industries | Health Technology |
to-BBB technologies BV
 to-BBB technologies BV Pharmaceuticals: MajorHealth Technology Develops medicines for brain disease treatment | Health Technology |
University of Lisbon
University of Lisbon Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharma AG
Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
Ultimovacs ASA
Ultimovacs ASA Pharmaceuticals: MajorHealth Technology Develops novel peptide based therapeutic cancer vaccine | Health Technology |
Mendus AB
 Mendus AB BiotechnologyHealth Technology Develops immunotherapies for therapeutic treatment of cancer | Health Technology |
Pfizer Saudi Ltd.
 Pfizer Saudi Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company that engaged in the discovery, development and manufacturing of healthcare products | Commercial Services |
The Leonard N Stern School of Business
 The Leonard N Stern School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ultimovacs AB
Ultimovacs AB Pharmaceuticals: MajorHealth Technology Engages in pharmaceutical development | Health Technology |
Ectin Research AB
 Ectin Research AB BiotechnologyHealth Technology Provides cancer therapy research services | Health Technology |
- Stock Market
- Insiders
- Carlos de Sousa
